Prognostic value of lymph node ratio beyond extranodal extension in node-positive oral cavity squamous cell carcinoma
Authors:
- Anuj KumarAKAnuj Kumar
- Sarbani Ghosh LaskarSLSarbani Ghosh Laskar
- Prashasti SharmaPSPrashasti Sharma
- Shwetabh SinhaSSShwetabh Sinha
- Samarpita MohantySMSamarpita Mohanty
- Ashwini BudrukkarABAshwini Budrukkar
- Monali SwainMSMonali Swain
- Gouri PantvaidyaGPGouri Pantvaidya
- Deepa NairDNDeepa Nair
- Shivakumar ThiagarajanSTShivakumar Thiagarajan
- Chandrashekhar DravidCDChandrashekhar Dravid
- Vidisha TuljapurkarVTVidisha Tuljapurkar
- 10 November 2026
- journal article
- Published by Elsevier in Radiotherapy and Oncology
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity CancerJAMA Otolaryngology–Head & Neck Surgery, 2019
- Extranodal extension in resected oral cavity squamous cell carcinoma: more to it than meets the eyeThe Laryngoscope, 2018
- Prognostic value of lymph node ratio in head and neck squamous cell carcinomaHead & Neck, 2018
- Lymph node density as a prognostic predictor in patients with betel nut-related oral squamous cell carcinomaClinical Oral Investigations, 2017
- Importance of lymph node ratio for locoregional recurrence of squamous cell carcinoma of the buccal mucosaHead & Neck, 2017
- Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234)Cancer, 2016
- Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomasCancer, 2016
- Lymph node ratio as an independent prognostic factor in oral squamous cell carcinomaHead & Neck, 2010
- Impact of nodal ratio on survival in squamous cell carcinoma of the oral cavityHead & Neck, 2009
- Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)Head & Neck, 2005